Acadia Pharmaceuticals Shares Rise With Co to Join S&P SmallCap 600

Dow Jones
01-01
 

By Kailyn Rhone

 

Shares of Acadia Pharmaceuticals rose after the company said it was set to join the S&P SmallCap 600 index.

The biopharmaceutical company's stock jumped 12% to $18.73 in morning trading Tuesday, though shares remain down around 40% for the year.

The San Diego company Tuesday said it will replace bank holding company Independent Bank Group, which is expected to be sold to SouthState Corp., in the small-cap index effective Jan. 3.

 

Write to Kailyn Rhone at kailyn.rhone@wsj.com

 

(END) Dow Jones Newswires

December 31, 2024 11:03 ET (16:03 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10